Evidence map›Paper›PMID 37680700›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2023

Real-World Study on Chai-Shi-Jie-Du Granules for the Treatment of Dengue Fever and the Possible Mechanisms Based on Network Pharmacology.

Huiqin Yang, Dehong Ma, Qin Li, Wen Zhou, Hongyi Chen, Xiyun Shan, Haipeng Zheng, Chun Luo, Zhiyue Ou, Jielan Xu and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 3 countries.

Huiqin YangInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, Guangdong, China.ORCID https://orcid.org/0000-0003-3858-6142
Dehong MaDepartment of Infectious Diseases, The People's Hospital of Xishuangbanna Dai Nationality Autonomous Prefecture, Xishuangbanna 666100, Yunnan, China.
Qin LiDepartment of Infectious Diseases, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, Fujian, China.
Wen ZhouDepartment of Infectious Diseases, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, Fujian, China.
Hongyi ChenDepartment of Infectious Diseases, The Ninth Hospital of Nanchang, Nanchang 330002, Jiangxi, China.
Xiyun ShanDepartment of Infectious Diseases, The People's Hospital of Xishuangbanna Dai Nationality Autonomous Prefecture, Xishuangbanna 666100, Yunnan, China.
Haipeng ZhengInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, Guangdong, China.
Chun LuoDepartment of Traditional Chinese Medicine, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, Guangdong, China.
Zhiyue OuInfectious Diseases Institute, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, Guangdong, China.
Jielan XuInfectious Diseases Institute, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, Guangdong, China.
Changtai WangInfectious Diseases Institute, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, Guangdong, China.
Lingzhai ZhaoDepartment of Clinical Laboratory, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, Guangdong, China.
Rui SuScientific Research Department, Capital Medical University Beijing Hospital of Traditional Chinese Medicine, Beijing 100010, China.
Yuehong ChenState Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, AMMS, Beijing100071, China.
Qingquan LiuScientific Research Department, Capital Medical University Beijing Hospital of Traditional Chinese Medicine, Beijing 100010, China.ORCID https://orcid.org/0000-0001-5589-9728
Xinghua TanDepartment of Traditional Chinese Medicine, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, Guangdong, China.
Luping LinDepartment of Traditional Chinese Medicine, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, Guangdong, China.ORCID https://orcid.org/0000-0001-6477-6324
Tao JiangState Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, AMMS, Beijing100071, China.ORCID https://orcid.org/0000-0003-1908-2926
Fuchun ZhangInfectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, Guangdong, China.ORCID https://orcid.org/0000-0001-8720-8565
Guangzhou Eighth People's Hospital · CNInfectious Diseases Institute · UGCapital Medical University · CNFujian Medical University · CNInstitute of Microbiology · BYXishuangbanna Tropical Botanical Garden · CNNinth Hospital of Nanchang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Traditional Chinese medicine (TCM) is a widely used method for treating dengue fever in China. TCM improves the symptoms of patients with dengue, but there is no standard TCM prescription for dengue fever. This real-world study aimed to evaluate the effects of Chai-Shi-Jie-Du (CSJD) granules for the treatment of dengue fever and the underlying mechanisms. Methods: We implemented a multicenter real-world study, an Results: 137 pairs of patients were successfully matched according to age, sex, and the time from onset to presentation. The time to defervescence (1.7 days vs. 2.5 days, Conclusions: CSJD granules exhibit high potential for the treatment of dengue fever, and the therapeutic mechanisms involved could be related to regulating immunity, moderating the oxidative stress response, and the response to lipopolysaccharide.

Identifiers

PMID37680700
PMCPMC10482559
OpenAlexW4386286809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.